株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

バイオチップの世界市場の予測

Global Biochips Market Forecast 2019-2028

発行 Inkwood Research 商品コード 603658
出版日 ページ情報 英文 325 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.53円で換算しております。
バイオチップの世界市場の予測 Global Biochips Market Forecast 2019-2028
出版日: 2020年05月18日 ページ情報: 英文 325 Pages
担当者のコメント
2020年5月出版の「バイオチップの世界市場の将来予測」は、近年注目を浴びているバイオチップの世界市場の現状及び将来を描きます。「DNAチップ」、「ラブオンチップ」、「タンパク質チップ」等のセグメントで市場サイズの情報が載ってあり、米国、英国、日本等の国レベルのデータもあります。研究から販売段階までのバリューチェーン詳細や競合環境も確認できる資料でございます。
概要

世界のバイオチップ市場は、2019年から2028年にかけて13.41%のCAGRで推移すると予測されています。バイオチップは、患者のプロファイルを作成するために、ひとつのサンプルで関連する検査のパネルを同時に分析する際に使用されるマイクロチップです。この患者プロファイルは、診断、疾患スクリーニング、疾患の進行度合いのモニタリング、または治療のモニタリングに使用されます。バイオチップは分子診断学において重要な役割を果たしており、POC診断への応用は個別化医療の開発を促進するものと期待されています。個別化医療をベースとした分析への重点化がバイオチップ市場の成長を後押ししています。個別化医療は、患者に早期診断を促し、最適な治療やリスク評価など低コストで改善された医療を提供します。

当レポートでは、世界のバイオチップ市場を調査し、市場の概要、タイプ・基材・エンドユーザー・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査範囲と調査手法

  • 調査目的
  • 調査範囲
  • 調査手法
  • 前提と制限

第2章 エグゼクティブサマリー

  • 市場規模と予測
  • 市場概要

第3章 市場力学

  • 市場の定義
  • 成長要因
    • 慢性疾患の罹患率の上昇
    • 個別化医薬品に対する関心の高まり
    • がん研究におけるプロテオミクスとゲノミクスの応用
    • POC診断の急速な拡大
  • 阻害要因
    • 計装コストの高さ
    • バイオチップ技術に関する一般の人々の認識不足
    • 代替技術:次世代シーケンシング(NGS)技術
    • 生物学的システムの複雑性
    • 一般的な規制基準の欠如

第4章 市場分析

  • 新型コロナウイルス感染症(COVID-19)の市場への影響
  • 主な投資洞察
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • オポチュニティマトリックス
  • ベンダー情勢
  • 主な購買基準
  • 規制の枠組み

第5章 世界のバイオチップ市場:タイプ別

  • DNAチップ
  • ラボオンチップ
  • プロテインチップ
  • その他

第6章 世界のバイオチップ市場:基材別

  • ガラス
  • ポリマー
  • シリコン
  • その他

第7章 世界のバイオチップ市場:エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 病院・診断センター
  • 学術研究機関

第8章 世界のバイオチップ市場:地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • ベルギー
    • ポーランド
    • その他
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • タイ
    • インドネシア
    • ベトナム
    • オーストラリア・ニュージーランド
    • その他
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第9章 企業プロファイル

  • ABBOTT LABORATORIES INC
  • AGILENT TECHNOLOGIES INC
  • BIOCHAIN INSTITUTE INC
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES INC
  • CEPHEID
  • CYBRDI INC
  • F HOFFMANN-LA ROCHE LTD
  • FLUIDIGM CORPORATION
  • GE HEALTHCARE
  • ILLUMINA INC
  • MERCK KGAA
  • PERKINELMER INC
  • RANDOX LABORATORIES LTD
  • THERMO FISHER SCIENTIFIC INC
図表

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - BIOCHIPS
  • TABLE 2: ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN 2018
  • TABLE 3: REGULATORY FRAMEWORK
  • TABLE 4: GLOBAL BIOCHIPS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: GLOBAL BIOCHIPS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL DNA CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: GLOBAL DNA CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 11: GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL CANCER DIAGNOSIS & TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 13: GLOBAL CANCER DIAGNOSIS & TREATMENT MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 15: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL GENE EXPRESSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 17: GLOBAL GENE EXPRESSION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 19: GLOBAL GENOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 21: GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL OTHER DNA CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 23: GLOBAL OTHER DNA CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL LAB ON A CHIP MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 25: GLOBAL LAB ON A CHIP MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 27: GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 29: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 31: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 33: GLOBAL GENOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL POINT OF CARE & IN VITRO DIAGNOSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 35: GLOBAL POINT OF CARE & IN VITRO DIAGNOSIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL PROTEOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 37: GLOBAL PROTEOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL OTHER LAB ON A CHIP MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 39: GLOBAL OTHER LAB ON A CHIP MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL PROTEIN CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 41: GLOBAL PROTEIN CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 43: GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 45: GLOBAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 46: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 47: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 48: GLOBAL EXPRESSION PROFILING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 49: GLOBAL EXPRESSION PROFILING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 50: GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 51: GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 52: GLOBAL PROTEOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 53: GLOBAL PROTEOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 54: GLOBAL OTHER PROTEIN CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 55: GLOBAL OTHER PROTEIN CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 56: GLOBAL OTHER TYPES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 57: GLOBAL OTHER TYPES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 58: GLOBAL BIOCHIPS MARKET, BY OTHER TYPES, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 59: GLOBAL BIOCHIPS MARKET, BY OTHER TYPES, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 60: GLOBAL CELL ARRAYS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 61: GLOBAL CELL ARRAYS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 62: GLOBAL TISSUE ARRAYS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 63: GLOBAL TISSUE ARRAYS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 64: PROPERTIES OF BIOCHIPS SUBSTRATE MATERIALS
  • TABLE 65: GLOBAL BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 66: GLOBAL BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 67: GLOBAL GLASS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 68: GLOBAL GLASS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 69: GLOBAL POLYMERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 70: GLOBAL POLYMERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 71: GLOBAL SILICON MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 72: GLOBAL SILICON MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 73: GLOBAL OTHER SUBSTRATE MATERIALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 74: GLOBAL OTHER SUBSTRATE MATERIALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 75: GLOBAL BIOCHIPS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 76: GLOBAL BIOCHIPS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 77: GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 78: GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 79: GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 80: GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 81: GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 82: GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 83: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 84: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 85: NORTH AMERICA BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 86: NORTH AMERICA BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 87: EUROPE BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 88: EUROPE BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 89: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 90: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 91: REST OF WORLD BIOCHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 92: REST OF WORLD BIOCHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: DEVELOPMENT OF BIOCHIPS
  • FIGURE 2: KEY INVESTMENT INSIGHTS
  • FIGURE 3: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: VALUE CHAIN ANALYSIS
  • FIGURE 7: KEY BUYING CRITERIA
  • FIGURE 8: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2019
  • FIGURE 9: GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, 2019-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY DNA CHIPS, IN 2019
  • FIGURE 11: GLOBAL BIOCHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL BIOCHIPS MARKET, BY CANCER DIAGNOSIS & TREATMENT, 2019-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL BIOCHIPS MARKET, BY GENE EXPRESSION, 2019-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL BIOCHIPS MARKET, BY GENOMICS, 2019-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL BIOCHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL BIOCHIPS MARKET, BY OTHER DNA CHIPS, 2019-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY LAB ON A CHIP, IN 2019
  • FIGURE 20: GLOBAL BIOCHIPS MARKET, BY CLINICAL DIAGNOSTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL BIOCHIPS MARKET, BY GENOMICS, 2019-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL BIOCHIPS MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL BIOCHIPS MARKET, BY PROTEOMICS, 2019-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL BIOCHIPS MARKET, BY OTHER LAB ON A CHIP, 2019-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY PROTEIN CHIPS, IN 2019
  • FIGURE 28: GLOBAL BIOCHIPS MARKET, BY DIAGNOSTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 29: GLOBAL BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)
  • FIGURE 30: GLOBAL BIOCHIPS MARKET, BY EXPRESSION PROFILING, 2019-2028 (IN $ MILLION)
  • FIGURE 31: GLOBAL BIOCHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2028 (IN $ MILLION)
  • FIGURE 32: GLOBAL BIOCHIPS MARKET, BY PROTEOMICS, 2019-2028 (IN $ MILLION)
  • FIGURE 33: GLOBAL BIOCHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2028 (IN $ MILLION)
  • FIGURE 34: GLOBAL BIOCHIPS MARKET, BY OTHER TYPES, 2019-2028 (IN $ MILLION)
  • FIGURE 35: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY OTHER TYPES, IN 2019
  • FIGURE 36: GLOBAL BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2028 (IN $ MILLION)
  • FIGURE 37: GLOBAL BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2028 (IN $ MILLION)
  • FIGURE 38: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY SUBSTRATE MATERIALS, IN 2019
  • FIGURE 39: GLOBAL BIOCHIPS MARKET, BY GLASS, 2019-2028 (IN $ MILLION)
  • FIGURE 40: GLOBAL BIOCHIPS MARKET, BY POLYMERS, 2019-2028 (IN $ MILLION)
  • FIGURE 41: GLOBAL BIOCHIPS MARKET, BY SILICON, 2019-2028 (IN $ MILLION)
  • FIGURE 42: GLOBAL BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2028 (IN $ MILLION)
  • FIGURE 43: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019
  • FIGURE 44: GLOBAL BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2028 (IN $ MILLION)
  • FIGURE 45: GLOBAL BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2028 (IN $ MILLION)
  • FIGURE 46: GLOBAL BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTES, 2019-2028 (IN $ MILLION)
  • FIGURE 47: NORTH AMERICA BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 48: UNITED STATES BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 49: CANADA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 50: EUROPE BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 51: UNITED KINGDOM BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 52: GERMANY BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 53: FRANCE BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 54: ITALY BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 55: RUSSIA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 56: BELGIUM BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 57: POLAND BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 58: REST OF EUROPE BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 59: ASIA PACIFIC BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 60: CHINA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 61: JAPAN BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 62: INDIA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 63: SOUTH KOREA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 64: INDONESIA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 65: THAILAND BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 66: VIETNAM BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 67: AUSTRALIA & NEW ZEALAND BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 68: REST OF ASIA PACIFIC BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 69: REST OF WORLD BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 70: LATIN AMERICA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 71: MIDDLE EAST & AFRICA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
目次
Product Code: 12926

KEY FINDINGS

The global biochips market is projected to register a CAGR of 13.41% during the forecast period of 2019-2028. Increasing incidences of chronic diseases, rising investments in medical and healthcare research, growth in personalized medicine, developing software and service sectors in proteomics and genomics, and rapidly growing use of point-of-care testing diagnosis are the principal factors contributing to the global market growth.

MARKET INSIGHTS

Biochip is a microchip used to simultaneously analyze a panel of related tests in a single sample producing a patient's profile. The patient profile can be used in diagnosis, disease screening, monitoring disease progression, or monitoring treatment. Biochips play an important role in molecular diagnostics, and their application in point-of-care diagnosis is expected to facilitate the development of personalized medicines. Emphasis on personalized medicine-based analytics is adding growth to the biochips market. Personalized medicines offer patients an early diagnosis, optimal treatments, risk assessments, low-cost improved healthcare. The success of personalized medicine depends upon information and record of reliable and accurate diagnostics.

The complexity of biological systems is a major challenge for the biochips market. The large-scale testing on a single chip creates complexity. Lab on a chip in the type segment collected the largest revenue share in 2019. Biotechnology and pharmaceutical companies are the fastest-growing end-users. There is a sustainable competitive advantage through innovations between companies in the market.

REGIONAL INSIGHTS

The global biochips market is surveyed geographically by segmenting into regions of Europe, Asia Pacific, North America, and the Rest of the World. The region of North America dominated the market in 2019 in terms of revenue, due to growing awareness about biochips and their widespread applications in various fields such as personalized medicine, clinical diseases, agri-genomics, and others.

COMPETITIVE INSIGHTS

The biochips market is highly competitive, dominated by well-established companies, and also multiple new players holding the majority of market share. Some of the participants competing in the market are Abbott Laboratories Inc, F. Hoffmann-La Roche Ltd, Randox Laboratories Ltd, GE Healthcare, Merck KGaA, etc.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

Market Segmentation cater to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. PARENT MARKET ANALYSIS: GENOMICS AND PROTEOMICS MARKET
  • 3.2. DEVELOPMENT OF BIOCHIPS
  • 3.3. MARKET DEFINITION
  • 3.4. KEY DRIVERS
    • 3.4.1. RISING INCIDENCES OF CHRONIC DISEASES
    • 3.4.2. GROWING INTEREST IN PERSONALIZED MEDICINES
    • 3.4.3. APPLICATION OF PROTEOMICS AND GENOMICS IN CANCER RESEARCH
    • 3.4.4. RAPIDLY GROWING USE OF POINT-OF-CARE TESTING DIAGNOSTICS
  • 3.5. KEY RESTRAINTS
    • 3.5.1. HIGH INSTRUMENTATION COST
    • 3.5.2. LACK OF AWARENESS AMONG COMMON PEOPLE ABOUT BIOCHIP TECHNOLOGY
    • 3.5.3. AVAILABILITY OF ALTERNATIVE TECHNOLOGY: NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY
    • 3.5.4. COMPLEXITY OF BIOLOGICAL SYSTEMS
    • 3.5.5. LACK OF COMMON REGULATORY STANDARDS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON BIOCHIPS
  • 4.2. KEY INVESTMENT INSIGHTS
  • 4.3. PORTER'S FIVE FORCE ANALYSIS
    • 4.3.1. BUYER POWER
    • 4.3.2. SUPPLIER POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. VALUE CHAIN ANALYSIS
    • 4.6.1. RESEARCH & DEVELOPMENT
    • 4.6.2. RAW MATERIALS
    • 4.6.3. MANUFACTURING
    • 4.6.4. WHOLESALERS/RETAILERS/DISTRIBUTORS
    • 4.6.5. END-USER
  • 4.7. KEY BUYING CRITERIA
    • 4.7.1. COST
    • 4.7.2. APPLICATIONS
    • 4.7.3. PRODUCT TYPE
  • 4.8. REGULATORY FRAMEWORK

5. MARKET BY TYPE

  • 5.1. DNA CHIPS
    • 5.1.1. AGRICULTURAL BIOTECHNOLOGY
    • 5.1.2. CANCER DIAGNOSIS & TREATMENT
    • 5.1.3. DRUG DISCOVERY
    • 5.1.4. GENE EXPRESSION
    • 5.1.5. GENOMICS
    • 5.1.6. SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
    • 5.1.7. OTHER DNA CHIPS
  • 5.2. LAB ON A CHIP
    • 5.2.1. CLINICAL DIAGNOSTICS
    • 5.2.2. DRUG DISCOVERY
    • 5.2.3. GENOMICS
    • 5.2.4. POINT OF CARE & IN VITRO DIAGNOSIS
    • 5.2.5. PROTEOMICS
    • 5.2.6. OTHER LAB ON A CHIP
  • 5.3. PROTEIN CHIPS
    • 5.3.1. DIAGNOSTICS
    • 5.3.2. DRUG DISCOVERY
    • 5.3.3. EXPRESSION PROFILING
    • 5.3.4. HIGH THROUGHPUT SCREENING
    • 5.3.5. PROTEOMICS
    • 5.3.6. OTHER PROTEIN CHIPS
  • 5.4. OTHER TYPES
    • 5.4.1. CELL ARRAYS
    • 5.4.2. TISSUE ARRAYS

6. MARKET BY SUBSTRATE MATERIALS

  • 6.1. GLASS
  • 6.2. POLYMERS
  • 6.3. SILICON
  • 6.4. OTHER SUBSTRATE MATERIALS

7. MARKET BY END-USER

  • 7.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
  • 7.2. HOSPITALS AND DIAGNOSTICS CENTERS
  • 7.3. ACADEMIC AND RESEARCH INSTITUTES

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. UNITED STATES
    • 8.1.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. UNITED KINGDOM
    • 8.2.2. GERMANY
    • 8.2.3. FRANCE
    • 8.2.4. ITALY
    • 8.2.5. RUSSIA
    • 8.2.6. BELGIUM
    • 8.2.7. POLAND
    • 8.2.8. REST OF EUROPE
  • 8.3. ASIA PACIFIC
    • 8.3.1. CHINA
    • 8.3.2. JAPAN
    • 8.3.3. INDIA
    • 8.3.4. SOUTH KOREA
    • 8.3.5. INDONESIA
    • 8.3.6. THAILAND
    • 8.3.7. VIETNAM
    • 8.3.8. AUSTRALIA & NEW ZEALAND
    • 8.3.9. REST OF ASIA PACIFIC
  • 8.4. REST OF WORLD
    • 8.4.1. LATIN AMERICA
    • 8.4.2. MIDDLE EAST & AFRICA

9. COMPANY PROFILES

  • 9.1. ABBOTT LABORATORIES INC
  • 9.2. AGILENT TECHNOLOGIES INC
  • 9.3. BIOCHAIN INSTITUTE INC
  • 9.4. BIOMERIEUX SA
  • 9.5. BIO-RAD LABORATORIES INC
  • 9.6. CEPHEID
  • 9.7. CYBRDI INC
  • 9.8. F HOFFMANN-LA ROCHE LTD
  • 9.9. FLUIDIGM CORPORATION
  • 9.10. GE HEALTHCARE
  • 9.11. ILLUMINA INC
  • 9.12. MERCK KGAA
  • 9.13. PERKINELMER INC
  • 9.14. RANDOX LABORATORIES LTD
  • 9.15. THERMO FISHER SCIENTIFIC INC